Jiangsu Cowin Biotech Co Ltd
SSE:688426
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Jiangsu Cowin Biotech Co Ltd
Free Cash Flow
Jiangsu Cowin Biotech Co Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jiangsu Cowin Biotech Co Ltd
SSE:688426
|
Free Cash Flow
-¥161.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-79%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Free Cash Flow
¥12.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Free Cash Flow
¥644.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
RemeGen Co Ltd
SSE:688331
|
Free Cash Flow
-¥147.1m
|
CAGR 3-Years
58%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Free Cash Flow
-¥1.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Free Cash Flow
-¥306.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jiangsu Cowin Biotech Co Ltd
Glance View
Jiangsu Cowin Biotech Co., Ltd. engages in the provision of molecular testing services as well as the research and development of molecular testing products. The company is headquartered in Taizhou, Jiangsu and currently employs 603 full-time employees. The company went IPO on 2022-10-25. The firm is also in the business of molecular testing services. Molecular detection products include molecular detection raw materials enzymes, nucleic acid preservation reagents, nucleic acid extraction and purification reagents and molecular diagnostic kits. The firm's products are exported to the United States, Peru, Germany and other countries and regions.
See Also
What is Jiangsu Cowin Biotech Co Ltd's Free Cash Flow?
Free Cash Flow
-161.7m
CNY
Based on the financial report for Dec 31, 2024, Jiangsu Cowin Biotech Co Ltd's Free Cash Flow amounts to -161.7m CNY.
What is Jiangsu Cowin Biotech Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-79%
Over the last year, the Free Cash Flow growth was 5%.
